These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
758 related articles for article (PubMed ID: 19346482)
41. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Chen K; Reiman EM; Alexander GE; Caselli RJ; Gerkin R; Bandy D; Domb A; Osborne D; Fox N; Crum WR; Saunders AM; Hardy J Am J Psychiatry; 2007 Jun; 164(6):916-21. PubMed ID: 17541051 [TBL] [Abstract][Full Text] [Related]
42. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease. Pardo JV; Lee JT; eNeuro; 2018; 5(1):. PubMed ID: 29497704 [TBL] [Abstract][Full Text] [Related]
43. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Oh H; Madison C; Villeneuve S; Markley C; Jagust WJ Cereb Cortex; 2014 Jun; 24(6):1609-18. PubMed ID: 23389995 [TBL] [Abstract][Full Text] [Related]
44. Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes. Riviere ME; Langbaum JB; Turner RS; Rinne JO; Sui Y; Cazorla P; Ricart J; Meneses K; Caputo A; Tariot PN; Reiman EM; Graf A Alzheimers Dement; 2024 Mar; 20(3):1839-1850. PubMed ID: 38145469 [TBL] [Abstract][Full Text] [Related]
45. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43. Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173 [TBL] [Abstract][Full Text] [Related]
47. Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner. Rubinski A; Dewenter A; Zheng L; Franzmeier N; Stephenson H; Deming Y; Duering M; Gesierich B; Denecke J; Pham AV; Bendlin B; Ewers M; Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1035-1049. PubMed ID: 38049659 [TBL] [Abstract][Full Text] [Related]
48. Differences in Daily Physical Activity by Alzheimer's Risk Markers Among Older Adults. Marino FR; Deal JA; Dougherty RJ; Bilgel M; Tian Q; An Y; Simonsick EM; Resnick SM; Ferrucci L; Spira AP; Wanigatunga AA; Schrack JA J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38742659 [TBL] [Abstract][Full Text] [Related]
49. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects. Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987 [TBL] [Abstract][Full Text] [Related]
50. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes. Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD; Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545 [TBL] [Abstract][Full Text] [Related]
51. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758 [TBL] [Abstract][Full Text] [Related]
56. Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease. Jagust WJ; Landau SM; Neurology; 2021 Mar; 96(9):e1347-e1357. PubMed ID: 33408147 [TBL] [Abstract][Full Text] [Related]
57. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
58. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070 [TBL] [Abstract][Full Text] [Related]
59. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease. Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364 [TBL] [Abstract][Full Text] [Related]